PSUSA/00002502/202503
PSUSA/00002502/202503
PSUSA/00002502/202503
Human medicines European public assessment report (EPAR): Puregon, follitropin beta, Date of authorisation: 02/05/1996, Revision: 37, Status: Authorised
Human medicines European public assessment report (EPAR): RotaTeq, rotavirus vaccine, live, Date of authorisation: 26/06/2006, Revision: 39, Status: Authorised
Human medicines European public assessment report (EPAR): Orgalutran, ganirelix, Date of authorisation: 16/05/2000, Revision: 26, Status: Authorised
EMA - European Consumer Organisation (BEUC) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 10 November 2025
List of medicines currently in PRIME scheme
Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Date of authorisation: 12/12/2024, Revision: 4, Status: Withdrawn
Agenda - Management Board meeting: 17-18 December 2025
Minutes of the PRAC meeting 27 - 30 October 2025
Human medicines European public assessment report (EPAR): Azacitidine Kabi, azacitidine, Date of authorisation: 05/01/2024, Revision: 2, Status: Authorised